Paul E. Mann's most recent trade in ASP Isotopes Inc was a trade of 978,466 Common Stock done . Disclosure was reported to the exchange on Sept. 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 978,466 | 6,824,093 | - | - | Common Stock | |
ASP Isotopes Inc | Paul E. Mann | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Jul 2024 | 39,984 | 5,845,627 | - | - | Common Stock | |
ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 718,143 | 5,805,643 | - | 0 | Common Stock | |
ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 1,000,000 | 5,087,500 | - | 0 | Common Stock | |
ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 1,000,000 | 4,087,500 | - | 0 | Common Stock | |
ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 15 Nov 2022 | 37,500 | 3,087,500 | - | 4 | 150,000 | Common Stock |
Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 16,907 (0%) | 0% | 0 | Common Stock | |
Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 49,084 | 49,084 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 38,590 | 38,590 (0%) | 0% | 0 | Common Stock | |
Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 19 Feb 2021 | 45,566 | 0 (0%) | 0% | 2.4 | 108,502 | Common Stock |
Abeona Therapeutics Inc | Paul E. Mann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 45,566 | 0 | - | - | Stock Option (Right to Buy) | |
Abeona Therapeutics Inc | Paul E. Mann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.28 per share. | 19 Feb 2021 | 45,566 | 45,566 (0%) | 0% | 1.3 | 58,324 | Common Stock |
Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 17 Feb 2021 | 132,664 | 0 (0%) | 0% | 2.3 | 310,168 | Common Stock |
Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 18 Dec 2020 | 17,079 | 772,907 (0%) | 0% | 1.6 | 27,099 | Common Stock |
Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 02 Dec 2020 | 30,488 | 789,986 (0%) | 0% | 1.5 | 45,369 | Common Stock |
Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 45,566 | 45,566 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Paul E. Mann | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 45,566 | 0 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 02 Nov 2020 | 30,488 | 820,474 (0%) | 0% | 1.0 | 31,589 | Common Stock |
Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2020 | 813,008 | 850,962 (1%) | 0% | 0 | Common Stock | |
Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 45,566 | 45,566 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 37,954 | 37,954 (0%) | 0% | 0 | Common Stock |